Interleukin (IL)-17A, F and AF in inflammation: A study in collagen-induced arthritis and rheumatoid arthritis

Clinical and Experimental Immunology

Volumn 177, Issue 3, 2014, Pages 652-661

  Sarkar, S ^a   Justa, S ^a   Brucks, M ^a   Endres, J ^b   Fox, D A ^b   Zhou, X ^a   Alnaimat, F ^a   Whitaker, B ^c   Wheeler, J C ^c   Jones, B H ^c   Bommireddy, S R ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Arthritis; Cytokine; Inflammation

Indexed keywords

AZATHIOPRINE; CD3 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17AF; INTERLEUKIN 17F; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARTHRITIS; CYTOKINE; INFLAMMATION;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; INTERLEUKIN-7; LEUKOCYTES, MONONUCLEAR; MALE; MICE; T-LYMPHOCYTE SUBSETS;

EID: 84904726792     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12376     Document Type: Article

References (36)

1. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467-476.
2. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14:155-174.
3. Lubberts E, Koenders MI, Oppers-Walgreen B etal. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50:650-659.
4. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171:6173-6177.
5. Yamaguchi Y, Fujio K, Shoda H etal. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol 2007; 179:7128-7136.
6. Shahrara S, Huang Q, Mandelin AM, 2nd, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10:R93.
7. Ziolkowska M, Koc A, Luszczykiewicz G etal. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000; 164:2832-2838.
8. Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 2011; 30:1201-1207.
9. Rosu A, Margaritescu C, Stepan A, Musetescu A, Ene M. IL-17 patterns in synovium, serum and synovial fluid from treatment-naive, early rheumatoid arthritis patients. Rom J Morphol Embryol 2012; 53:73-80.
10. Moran EM, Mullan R, McCormick J etal. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther 2009; 11:R113.
11. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005; 19:180-184.
12. Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 2009; 160:319-324.
13. Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 2009; 182:3112-3120.
14. Hot A, Miossec P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 2011; 70:727-732.
15. Sarkar S, Cooney LA, White P etal. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 2009; 11:R158.
16. Shi L, Wheeler JC, Sweet RW etal. De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins. J Mol Biol 2010; 397:385-396.
17. Yang XO, Pappu BP, Nurieva R etal. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008; 28:29-39.
18. Sarkar S, Fox DA. Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum Dis Clin North Am 2010; 36:345-366.
19. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-852.
20. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004; 114:1265-1273; quiz 1274.
21. Jovanovic DV, Di Battista JA, Martel-Pelletier J etal. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160:3513-3521.
22. Cai XY, Gommoll CP, Jr, Justice L, Narula SK, Fine JS. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol Lett 1998; 62:51-58.
23. Schwarzenberger P, Huang W, Ye P etal. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 2000; 164:4783-4789.
24. Zwerina K, Koenders M, Hueber A etal. Anti IL-17A therapy inhibits bone loss in TNF-alpha-mediated murine arthritis by modulation of the T-cell balance. Eur J Immunol 2012; 42:413-423.
25. Hot A, Zrioual S, Toh ML, Lenief V, Miossec P. IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Ann Rheum Dis 2011; 70:341-348.
26. DeForge LE, Loyet KM, Delarosa D etal. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. J Immunol Methods 2010; 362:70-81.
27. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205-1213.
28. Bax M, van Heemst J, Huizinga TW, Toes RE. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 2011; 63:459-466.
29. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117:801-806.
30. Adamik J, Henkel M, Ray A, Auron PE, Duerr R, Barrie A. The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells. Cytokine 2013; 64:404-412.
31. Melton AC, Melrose J, Alajoki L etal. Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation. PLOS ONE 2013; 8:e58966.
32. Krejsgaard T, Litvinov IV, Wang Y etal. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood 2013; 122:943-950.
33. Rauen T, Hedrich CM, Juang YT, Tenbrock K, Tsokos GC. cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J Biol Chem 2011; 286:43437-43446.
34. Hedrich CM, Rauen T, Kis-Toth K, Kyttaris VC, Tsokos GC. cAMP-responsive element modulator alpha (CREMalpha) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J Biol Chem 2012; 287:4715-4725.
35. Toy D, Kugler D, Wolfson M etal. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006; 177:36-39.
36. Hueber AJ, Asquith DL, Miller AM etal. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010; 184:3336-3340.